Cite
HARVARD Citation
Leslie, J. et al. (2022). CXCR2 inhibition enables NASH-HCC immunotherapy. Gut. 71 (10), pp. 2093-2106. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Leslie, J. et al. (2022). CXCR2 inhibition enables NASH-HCC immunotherapy. Gut. 71 (10), pp. 2093-2106. [Online].